140 related articles for article (PubMed ID: 9864912)
1. Prophylactic platelet transfusion in acute leukemia: which threshold should be used.
Finazzi G
Haematologica; 1998 Nov; 83(11):961-2. PubMed ID: 9864912
[No Abstract] [Full Text] [Related]
2. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E
Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920
[TBL] [Abstract][Full Text] [Related]
3. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy.
Oka S; Muroi K; Mori M; Matsuyama T; Fujiwara S; Oh I; Ono Y; Kikuchi S; Sato K; Ueda M; Toshima M; Ozaki K; Takatoku M; Nagai T; Ozawa K
Intern Med; 2007; 46(19):1669-70. PubMed ID: 17917331
[No Abstract] [Full Text] [Related]
5. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?
Benjamin RJ; Anderson KC
Crit Rev Oncol Hematol; 2002 May; 42(2):163-71. PubMed ID: 12007974
[TBL] [Abstract][Full Text] [Related]
6. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions.
Friedmann AM; Sengul H; Lehmann H; Schwartz C; Goodman S
Transfus Med Rev; 2002 Jan; 16(1):34-45. PubMed ID: 11788928
[TBL] [Abstract][Full Text] [Related]
7. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
[TBL] [Abstract][Full Text] [Related]
8. [Thrombocyte substitution in children under cytostatic therapy].
Wernet D; Schnaidt M; Klingebiel T; Schneider W
Beitr Infusionther Klin Ernahr; 1986; 15():172-8. PubMed ID: 3463300
[No Abstract] [Full Text] [Related]
9. An audit of platelet transfusion within the Wellington Cancer Centre.
Buhrkuhl DC; Karlsson MK; Carter JM
Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
[TBL] [Abstract][Full Text] [Related]
10. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
Estcourt LJ; Stanworth SJ; Murphy MF
JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods.
Apelseth TO; Bruserud O; Wentzel-Larsen T; Hervig T
Transfusion; 2010 Apr; 50(4):766-75. PubMed ID: 20030789
[TBL] [Abstract][Full Text] [Related]
12. Images in haematology. Candida glabrata in a blood film.
Arnold JA; Jowzi Z; Bain BJ
Br J Haematol; 1999 Jan; 104(1):1. PubMed ID: 10027704
[No Abstract] [Full Text] [Related]
13. Platelet support and the use of cytokines.
Bishop JF
Stem Cells; 1994 Jul; 12(4):370-7. PubMed ID: 7524892
[TBL] [Abstract][Full Text] [Related]
14. Current issues with platelet transfusion in patients with cancer.
McCullough J
Semin Hematol; 2000 Apr; 37(2 Suppl 4):3-10. PubMed ID: 10831283
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic platelet transfusions.
Estcourt LJ; Stanworth SJ; Murphy MF
Curr Opin Hematol; 2010 Sep; 17(5):411-7. PubMed ID: 20601869
[TBL] [Abstract][Full Text] [Related]
16. Indications for platelet transfusion in children with acute leukemia.
Murphy S; Litwin S; Herring LM; Koch P; Remischovsky J; Donaldson MH; Evans AE; Gardner FH
Am J Hematol; 1982 Jun; 12(4):347-56. PubMed ID: 6981349
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for prophylactic platelet transfusions: need for a concurrent outcomes management system.
Shulkin DJ; Fox KR; Stadtmauer EA
QRB Qual Rev Bull; 1992 Dec; 18(12):477-9. PubMed ID: 1287532
[No Abstract] [Full Text] [Related]
18. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
Heckman KD; Weiner GJ; Davis CS; Strauss RG; Jones MP; Burns CP
J Clin Oncol; 1997 Mar; 15(3):1143-9. PubMed ID: 9060557
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
[TBL] [Abstract][Full Text] [Related]
20. Refractory thrombocytopenia in a 27-year-old female following allogeneic bone marrow transplantation.
Colman RW; Rao AK; Rubin RN
Am J Hematol; 1993 Dec; 44(4):284-8. PubMed ID: 8238002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
